Who makes [14C]-Omaveloxolone?

[14C]-Omaveloxolone is developed by Biogen.

What development phase is [14C]-Omaveloxolone in?

[14C]-Omaveloxolone is in Phase 1.

Last reviewed 2026-04-19 · How we verify

[14C]-Omaveloxolone

Biogen · Phase 1 active Small molecule

At a glance

Generic name	[14C]-Omaveloxolone
Also known as	[14C]-RTA 408
Sponsor	Biogen
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

[14C]-Omaveloxolone CI brief — competitive landscape report
[14C]-Omaveloxolone updates RSS · CI watch RSS
Biogen portfolio CI